Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats
Biopharmaceutics & Drug Disposition · 2020-02 · 41 (1-2) · 54-63
DOI: 10.1002/bdd.2213 ↗At a glance
Journal article in Biopharmaceutics & Drug Disposition, published online on 2020-01-22. Written by Daifei Wang and 7 co-authors. Institution: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China. Cited 49 times so far (Crossref); 23 references. Funded by: National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Construction Foundation.
Abstract (original language)
Salvia miltiorrhiza is one of the most commonly used traditional Chinese medicines in the treatment of cardiovascular and cerebrovascular diseases. Cryptotanshinone (CTS), tanshinone IIA (Tan IIA), dihydrotanshinone I (diTan I), and tanshinone I (Tan I) are the main active compounds in the liposoluble extract of Salvia miltiorrhiza. The differences in the pharmacokinetic and tissue distribution behaviors of the four tanshinones after oral administration of the liposoluble extract of Salvia miltiorrhiza and pure compounds are not clear. This study aims to compare the pharmacokinetics and tissue distribution of the four tanshinones after oral administration of pure tanshinone monomers and the liposoluble extract of Salvia miltiorrhiza. An ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) analysis method was developed for the determination of the four tanshinones. The results showed that the AUC and C max of tanshinones in rats receiving the extract of Salvia miltiorrhiza were significantly increased compared with those receiving the pure tanshinones. In the tissue distribution experiments, the AUC of the four tanshinones in the extract was much greater than the AUC of the monomers in the lung, heart, kidney, liver, and brain, and the coexisting constituents particularly promoted the distribution of tanshinones into tissues that the drug cannot sufficiently penetrate. These findings suggested that the coexisting constituents in the liposoluble extract of Salvia miltiorrhiza play an important role in the alteration of plasma concentration and tissue distribution of the four tanshinones. Understanding these differences could be of significance for the development and application of Salvia miltiorrhiza extract and tanshinone components.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
- School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, China.
ORCID profiles: Jing Jin
Funding
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Construction Foundation
Cite
APA
Wang, D., Yu, W., Cao, L., Xu, C., Tan, G., Zhao, Z., Huang, M., & Jin, J. (2020). Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats. Biopharmaceutics & Drug Disposition, 41(1-2), 54-63. https://doi.org/10.1002/bdd.2213
Vancouver
Wang D, Yu W, Cao L, Xu C, Tan G, Zhao Z, et al. Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats. Biopharmaceutics & Drug Disposition. 2020;41(1-2):54-63. doi:10.1002/bdd.2213
BibTeX
@article{Wang2020,
author = {Wang, Daifei and Yu, Weibang and Cao, Lin and Xu, Chuncao and Tan, Guoyao and Zhao, Zhongxiang and Huang, Min and Jin, Jing},
title = {Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats},
journal = {Biopharmaceutics & Drug Disposition},
year = {2020},
volume = {41},
number = {1-2},
pages = {54--63},
doi = {10.1002/bdd.2213}
}
EUVIMED